Last updated on April 2019

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma


Brief description of study

The primary objective of this study is to evaluate the tolerability and safety of a combination of lenvatinib plus nivolumab in participants with hepatocellular carcinoma (HCC).

Clinical Study Identifier: NCT03418922

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.